the effects of salbutamol 0.225 mg/kg given systemically on lung function in infants have been measured by whole-body plethysmography in 60 children with broncho-pulmonary diseases ( 24 after respiratory distress syndrome , 21 with wheezy bronchitis and 15 with cystic fibrosis ) .
C0021270
infants
C0008059
children